|
|
|
|
| LEADER |
03556nam a22004695i 4500 |
| 001 |
978-4-431-55894-1 |
| 003 |
DE-He213 |
| 005 |
20160401165425.0 |
| 007 |
cr nn 008mamaa |
| 008 |
160401s2016 ja | s |||| 0|eng d |
| 020 |
|
|
|a 9784431558941
|9 978-4-431-55894-1
|
| 024 |
7 |
|
|a 10.1007/978-4-431-55894-1
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a R895-920
|
| 072 |
|
7 |
|a MMN
|2 bicssc
|
| 072 |
|
7 |
|a MED080000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.07548
|2 23
|
| 245 |
1 |
0 |
|a Perspectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy
|h [electronic resource] /
|c edited by Yuji Kuge, Tohru Shiga, Nagara Tamaki.
|
| 264 |
|
1 |
|a Tokyo :
|b Springer Japan :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a XVI, 326 p. 125 illus., 93 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a Part 1. Instrument and data analysis 1 -- Review 1 2 -- Review 2 3 -- Topics 1 4 -- Topics 2 5 -- Topics 3 Part 2. Biomarker and molecular probes 6 -- Review 1 7 -- Review 2 8 -- Topics 1 9 -- Topics 2 10 -- Topics 3 Part 3. Cardiology 11 -- Review 1 12 -- Review 2 13 -- Topics 1 14 -- Topics 2 15 -- Topics 3 Part 4. Neurology 16 -- Review 1 17 -- Review 2 18 -- Topics 1 19 -- Topics 2 20 -- Topics 3 Part 5. Oncology 21 -- Review 1 22 -- Review 2 23 -- Topics 1 24 -- Topics 2 25 -- Topics 3 26 -- Topics 4.
|
| 506 |
0 |
|
|a Open Access
|
| 520 |
|
|
|a This work is devoted to understanding the recent advances in nuclear medicine and molecular imaging technologies along with their application to integrated medical therapy and future drug development. This anthology is based on the international symposium in 2015 entitled “Perspective on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy. “The symposium provided an opportunity to exchange ideas on how to promote nuclear medicine technology and how to extend the technology to medical therapy and drug development, and was also a good opportunity to discuss the future perspective of nuclear medicine and molecular imaging by worldwide leaders in the field. Molecular imaging technologies have been rapidly developed worldwide in recent years. Among those developments, nuclear medicine has come to play an important role in quantitative analysis of biological process in vivo as well as in wide clinical use. With the current progress of nuclear medicine and molecular imaging, this modality has been applied for treatment monitoring and predicting its outcome with the use of optimal imaging biomarkers and suitable quantitative analysis. Truly, a new era has arrived with clinical use of nuclear medicine and molecular imaging for personalized medicine. This volume will benefit a wide variety of researchers in life science including those working in drug development, molecular imaging, and medical therapy as well as physicians who utilize diagnostic imaging.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Radiology.
|
| 650 |
|
0 |
|a Nuclear medicine.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Nuclear Medicine.
|
| 650 |
2 |
4 |
|a Diagnostic Radiology.
|
| 700 |
1 |
|
|a Kuge, Yuji.
|e editor.
|
| 700 |
1 |
|
|a Shiga, Tohru.
|e editor.
|
| 700 |
1 |
|
|a Tamaki, Nagara.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9784431558927
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-4-431-55894-1
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
